Viral hepatitis estimates among key populations in Canada, 2021 (infographic)

Download in PDF format
(152 KB, 1 page)

Organization: Public Health Agency of Canada

Date published: 2025-01-17

Hepatitis B and C disproportionately affect certain populations and communitiesFootnote 1.

Hepatitis C

An estimated 0.56% of the general populationFootnote 2 were living with chronic hepatitis CFootnote 3. An estimated 0.99% of the general population ever had hepatitis CFootnote 4.

The estimated proportion of people who had hepatitis C varies across key populations:

The estimated proportion of people living with chronic hepatitis C was the highest among people who inject drugs.

The estimated number of people living with chronic hepatitis C was the highest among adults born between 1945 and 1975.

There was insufficient information to provide national estimates among Inuit and Métis Peoples, and estimates of awareness for some key populations.

Hepatitis B

An estimated 0.68% of the general population were living with chronic hepatitis BFootnote 8.

The estimated proportion of people who had hepatitis B varies across key populations:

The highest estimated proportion and number of people living with chronic hepatitis B were among immigrants from countries where hepatitis B is common.

There was insufficient information to provide national estimates among people who inject drugs, First Nations, Inuit and Métis Peoples and people incarcerated in provincial prisons, and estimates of awareness for all key populations.

Although the overall viral hepatitis burden is low in the general Canadian population, the 2021 national estimates indicate that certain populations and communities remain disproportionately affected, and that a significant number of people in Canada would benefit from targeted testing and treatment.

Footnotes

Footnote 1

Due to the extensive overlap between these key populations, they were not considered to be mutually exclusive. Methods, full results and reference list available in Périnet S. et al., National hepatitis B and C estimates for 2021: measuring Canada's progress towards eliminating viral hepatitis as a public health concern, Canada Communicable Disease Report (submitted).

Return to footnote 1 referrer

Footnote 2

General population estimates and Canada's progress towards elimination available at https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/diseases-conditions/progress-towards-eliminating-viral-hepatitis-threat-2021/progress-towards-eliminating-viral-hepatitis-threat-2021.pdf.

Return to footnote 2 referrer

Footnote 3

This represents people with viremic infection as a proxy for chronic hepatitis C.

Return to footnote 3 referrer

Footnote 4

This represents people living with positive hepatitis C virus antibody status, including those with chronic hepatitis C, those who spontaneously resolved the infection, and those with treatment-related cure.

Return to footnote 4 referrer

Footnote 5

Within the past 12 months.

Return to footnote 5 referrer

Footnote 6

Population size was estimated using a direct multiplier method.

Return to footnote 6 referrer

Footnote 7

Country or regional hepatitis C virus antibody prevalence estimate 2% or greater.

Return to footnote 7 referrer

Footnote 8

This represents people with positive hepatitis B surface antigen as a proxy for chronic hepatitis B.

Return to footnote 8 referrer

Footnote 9

Country or regional hepatitis B surface antigen prevalence estimate 2% or greater.

Return to footnote 9 referrer

Page details

Date modified: